Back to Rankings

ENLV

EnlivexB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Curated Events
1
Active
Recent Headlines
7
New
Recent news sentiment
+0.1
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day

Curated events

Materiality
72
capital return
Source
External coverage
Decided
2026-05-24
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program

Enlivex paired a $21 million debt financing with a $20 million share repurchase program and token-related updates. The buyback is a supportive capital-return signal, but the new debt and mixed non-core updates make the net read-through only mildly positive and still somewhat unclear.

Sentiment decomposition

+0.1
30-day score
Company-55%
Macro-30%
Pulse-15%
The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

As of 2026-05-24 • Updated scheduledSource: News desk